Egr-1 promotes cell proliferation and invasion by increasing β-catenin expression in gastric cancer

Digestive Diseases and Sciences

Volumn 58, Issue 2, 2013, Pages 423-430

  Sun, Ting ^a   Tian, Hua ^a   Feng, Yu Guang ^b   Zhu, Ya Qin ^a   Zhang, Wei Qian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

catenin; Egr 1; Gastric cancer; Invasion

Indexed keywords

BETA CATENIN; CYCLIN D1; EARLY GROWTH RESPONSE FACTOR 1; CTNNB1 PROTEIN, HUMAN; EGR1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE S PHASE; CELL INVASION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING; WOUND HEALING; AGED; CANCER INVASION; CELL MOTION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE;

AGED; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSFECTION; UP-REGULATION;

MLCS; MLOWN;

EID: 84876343571     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2356-4     Document Type: Article

References (21)

1. Baron V, Adamson ED, Calogero A, Ragona G, Mercola D. The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther. 2006;13:115-124.
2. Adamson E, de Belle I, Mittal S, et al. Egr1 signaling in prostate cancer. Cancer Biol Ther. 2003;2:617-622.
3. Abdulkadir SA. Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1. Ann N Y Acad Sci. 2005;1059:33-40.
4. Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED, Mercola D. Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes. J Biol Chem. 2003;278:11802-11810.
5. Sauer L, Gitenay D, Vo C, Baron VT. Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells. Oncogene. 2010;29:2628-2637.
6. Boone DN, Qi Y, Li Z, Hann SR. Egr1 mediates p53-independent c-Myc induced apoptosis via a non canonical ARF-dependent transcriptional mechanism. Proc Natl Acad Sci USA. 2011;108:632-637.
7. Shareef MM, Cui N, Burikhanov R, Gupta S, Satishkumar S, et al. Role of tumor necrosis factor-alpha and TRAIL in high-dose radiation-induced bystander signaling in lung adenocarcinoma. Cancer Res. 2007;67:11811-11820.
8. Kobayashi D, Yamada M, Kamagata C, et al. Overexpression of early growth response-1 as a metastasis-regulatory factor in gastric cancer. Anticancer Res. 2002;22:3963-3970.
9. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 2003;1653:1-24.
10. Takasu S, Tsukamoto T, Cao XY, et al. Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and beta-catenin activation in gastric carcinogenesis in N-methyl-N-nitrosourea-treated K19-C2mE transgenic mice. Cancer Sci. 2008;99:2356-2364.
11. Yoon CS, Hyung WJ, Lee JH, et al. Expression of S100A4, E-cadherin, alpha- and beta-catenin in gastric adenocarcinoma. Hepatogastroenterology. 2008;55:1916-1920.
12. Dvory-Sobol H, Sagiv E, Liberman E, Kazanov D, Arber N. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway. Cancer. 2007;109:188-197.
13. Dvory-Sobol H, Sagiv E, Kazanov D, Ben-Ze'ev A, Arber N. Targeting the active beta-catenin pathway to treat cancer cells. Mol Cancer Ther. 2006;5:2861-2871.
14. de Belle I, Huang RP, Fan Y, Liu C, Mercola D, Adamson ED. p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene. 1999;18:3633-3642.
15. Yu J, Zhang SS, Saito K, et al. PTEN regulation by Akt-EGR1-ARF-PTEN axis. EMBO J. 2009;28:21-33.
16. Kim J, Lee YH, Kwon TK, Chang JS, Chung KC, Min DS. Phospholipase D prevents etoposide-induced apoptosis by inhibiting the expression of early growth response-1 and phosphatase and tensin homologue deleted on chromosome 10. Cancer Res. 2006;66:784-793.
17. Mahalingam D, Natoni A, Keane M, Samali A, Szegezdi E. Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells. Br J Cancer. 2010;102:754-764.
18. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA. 1999;96:5522-5527.
19. Gnad T, Feoktistova M, Leverkus M, Lendeckel U, Naumann M. Helicobacter pylori-induced activation of beta-catenin involves low density lipoprotein receptor-related protein 6 and dishevelled. Mol Cancer. 2010;9:31.
20. Lee SH, Kang HJ, Shin DH, et al. Expression of beta-catenin and its mechanism of delocalization in intestinal-type early gastric cancer based on mucin expression. Histol Histopathol. 2009;24:831-838.
21. Saegusa M, Hashimura M, Kuwata T, et al. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells. J Pathol. 2008;216:521-532.